Newest medicines work just as well at half dosage for stable psoriasis
Peer-Reviewed Publication
Updates every hour. Last Updated: 1-Jun-2026 20:15 ET (2-Jun-2026 00:15 GMT/UTC)
Three-quarters of people who respond well to the newest types of biologics for psoriasis can safely reduce their dosage, often even by half. These medications then work just as effectively, according to a study led by Radboud university medical center and Ghent University Hospital. The finding results in fewer injections and saves up to €8,500 per patient per year.
A new study from the University of Exeter, published in the Lancet Diabetes and Endocrinology, which found that genetic testing can identify the cause of pancreatic agenesis in 98 per cent of cases.
The study, funded by Wellcome and supported by the National Institute for Health and Care Research Exeter Biomedical Research Centre, identified the DNA changes responsible for pancreatic agenesis in all but four of 129 study participants.
Elli Theobald, University of Washington assistant professor of biology, aims to connect the biology concepts her students learn in class to real-world issues, something she hopes will help both retain students in the biology major at the UW and help non-majors in the class with their future careers. How common is it for educational materials — such as guidelines or test questions — to include connections to society? In a recent paper, Theobald and her team examined almost 3,000 science guidelines and assessment questions from 16 sources to answer this question. Of the approximately 200 elements — about 7% — that had real-world implications, many discussed ethics and public health issues.
A new study from Keck Medicine of USC quantifies how often BMI may miss cases of obesity. The research shows that one quarter of people considered to have a normal (healthy) BMI meet the standard of clinical obesity. And 50% of those deemed overweight by their BMI would be reclassified as obese.